Rueda-Robles Ascensión, Rodríguez-Lara Avilene, Meyers Matthew S, Sáez-Lara María José, Álvarez-Mercado Ana I
Department of Nutrition and Food Science, Faculty of Pharmacy, University of Granada, Campus Universitario s/n, 18071 Granada, Spain.
Institute of Nutrition and Food Technology "José Mataix", Biomedical Research Center, Parque Tecnológico Ciencias de la Salud, University of Granada, 18016 Granada, Spain.
Pathogens. 2022 Aug 29;11(9):986. doi: 10.3390/pathogens11090986.
Diseases caused by bacteria cause millions of deaths every year. In addition, the problem of resistance to antibiotics is so serious that it threatens the achievements of modern medicine. This is a very important global problem as some bacteria can also develop persistence. Indeed, the persistence of pathogenic bacteria has evolved as a potent survival strategy to overcome host organisms' defense mechanisms. Additionally, chronic or persistent infections may be caused by persisters which could facilitate antibiotic resistance. Probiotics are considered good bacteria. It has been described that the modulation of gut microbiota by probiotics could have a great potential to counteract the deleterious impact and/or regulate gut microbiota after bacterial infection. Probiotics might provide health benefits through the inhibition of pathogen growth or the replacement of pathogenic bacteria. Bearing in mind that current strategies to avoid bacterial persistence and prevent antibiotic resistance are not effective, other strategies need to be assessed. We have carried out a comprehensive review, which included the reported literature between 2016 and 2021, highlighting the clinical trials that reported the probiotics' potential to regulate gut microbiota after bacterial infection and focusing in particular on the context of antibiotic resistance and persister cells.
由细菌引起的疾病每年导致数百万人死亡。此外,抗生素耐药性问题非常严重,威胁到现代医学的成就。这是一个非常重要的全球性问题,因为一些细菌还会产生持续性。事实上,病原菌的持续性已经演变成一种强大的生存策略,以克服宿主生物体的防御机制。此外,持续性感染可能由持留菌引起,这可能会促进抗生素耐药性。益生菌被认为是有益菌。据描述,益生菌对肠道微生物群的调节可能具有巨大潜力,可抵消细菌感染后的有害影响和/或调节肠道微生物群。益生菌可能通过抑制病原体生长或替代病原菌来提供健康益处。鉴于目前避免细菌持续性和预防抗生素耐药性的策略并不有效,需要评估其他策略。我们进行了一项全面综述,其中包括2016年至2021年期间报道的文献,突出了那些报道益生菌在细菌感染后调节肠道微生物群潜力的临床试验,并特别关注抗生素耐药性和持留菌细胞的背景。